Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes

碳纳米管诱导肿瘤转化和癌症干细胞

基本信息

  • 批准号:
    8846114
  • 负责人:
  • 金额:
    $ 33.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-06 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Nanotechnology holds great promise as the next industrial revolution and is expect to be a major driving force for the U.S. economic recovery and development. The long-term objective of this project is to enable safe nanotechnology through the understanding of biochemical mechanisms and physicochemical factors influencing the adverse health effects of nanomaterial exposure. This proposal specifically addresses the carcinogenic effects of carbon nanotubes (CNT) following chronic pulmonary exposure. Lung cancer is the leading cause of cancer death, and environmental and occupational exposure is the major cause of most cases. Recent studies have shown that CNT can induce tumors and tumor-associated pathologies, but the underlying mechanisms and key contributing factors are unclear, which limits human risk assessment and disease prevention. We hypothesize that chronic exposure of human lung epithelial cells to CNT induces malignant transformation and carcinogenesis through complex mechanisms that involve p53 dysregulation and induction of cancer stem cells (CSC) and epithelial mesenchymal transition (EMT). We also propose that combination biomarkers that characterize these biological changes could be predictive of CNT-induced carcinogenesis. Three specific aims are proposed. In Aim 1, we will test the requirement of p53 dysregulation in CNT carcinogenesis and determine key physicochemical properties controlling CNT carcinogenicity. Aim 2 will study the role of CSC in CNT carcinogenesis and determine the unique CSC markers for CNT carcinogenic responses. Aim 3 will characterize the EMT network and determine its role in CSC acquisition and CNT carcinogenesis. We will identify combination biomarkers to predict CNT carcinogenesis and validate their pre- clinical use in lung orthotopic xenograft models. Our expectations are that, at the conclusion of this project, we will have determined the biomarkers for CNT carcinogenesis and identified key physicochemical factors determining the carcinogenicity of CNT. This work is important because of the overall impact it will have on risk assessment and prevention of CNT carcinogenesis and development of safe nanotechnology. We expect the impact to be broad since the findings from this project are highly applicable to various nanomaterials. The proposed work is innovative because it combines the novel concepts of CSC and EMT to unveil the underlying mechanisms of CNT-induced carcinogenesis which are largely unknown at present. In addition, the experimental models developed in this project, e.g. chronic exposure and lung orthotopic xenograft models, could be used as predictive screening tools for carcinogenicity testing of nanomaterials which are currently lacking and greatly needed.
描述(由申请人提供):纳米技术作为下一次工业革命具有巨大的前景,有望成为美国经济复苏和发展的主要推动力。该项目的长期目标是通过了解影响纳米材料接触对健康不利影响的生化机制和理化因素,实现安全的纳米技术。本提案专门针对慢性肺暴露后碳纳米管(CNT)的致癌作用。肺癌是癌症死亡的主要原因,而环境和职业暴露是大多数病例的主要原因。最近的研究表明,碳纳米管可以诱导肿瘤和肿瘤相关病理,但其潜在机制和关键影响因素尚不清楚,这限制了人类风险评估和疾病预防。我们假设人类肺上皮细胞长期暴露于碳纳米管诱导恶性转化和癌变的复杂机制涉及p53失调和诱导癌症干细胞(CSC)和上皮间充质转化(EMT)。我们还提出,表征这些生物学变化的联合生物标志物可以预测碳纳米管诱导的致癌作用。提出了三个具体目标。在Aim 1中,我们将测试p53失调在碳纳米管癌变中的要求,并确定控制碳纳米管致癌性的关键理化性质。目的2将研究CSC在碳纳米管癌变中的作用,并确定碳纳米管癌变反应的独特CSC标志物。目的3将表征EMT网络并确定其在CSC获得和CNT癌变中的作用。我们将确定联合生物标志物来预测碳纳米管癌变,并验证其在肺原位异种移植模型中的临床前应用。我们的期望是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yon Rojanasakul其他文献

Yon Rojanasakul的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yon Rojanasakul', 18)}}的其他基金

Nanoparticle Fibrogenicity and Fibroblast Stem-Like Cells
纳米颗粒成纤维性和成纤维细胞样细胞
  • 批准号:
    9212809
  • 财政年份:
    2016
  • 资助金额:
    $ 33.53万
  • 项目类别:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
碳纳米管诱导肿瘤转化和癌症干细胞
  • 批准号:
    8691555
  • 财政年份:
    2014
  • 资助金额:
    $ 33.53万
  • 项目类别:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
碳纳米管诱导肿瘤转化和癌症干细胞
  • 批准号:
    9024527
  • 财政年份:
    2014
  • 资助金额:
    $ 33.53万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8268403
  • 财政年份:
    2010
  • 资助金额:
    $ 33.53万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8463235
  • 财政年份:
    2010
  • 资助金额:
    $ 33.53万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    8111227
  • 财政年份:
    2010
  • 资助金额:
    $ 33.53万
  • 项目类别:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
碳纳米管诱导纤维化的预测及机制
  • 批准号:
    7983999
  • 财政年份:
    2010
  • 资助金额:
    $ 33.53万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7838821
  • 财政年份:
    2009
  • 资助金额:
    $ 33.53万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7100360
  • 财政年份:
    2006
  • 资助金额:
    $ 33.53万
  • 项目类别:
Regulation of Fas-Mediated Lung Cell Apoptosis
Fas 介导的肺细胞凋亡的调节
  • 批准号:
    7579060
  • 财政年份:
    2006
  • 资助金额:
    $ 33.53万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了